Table 1.
The table provides demographic and clinical data of COVID-TB patients.
| Characteristics of patients | Number of patients (%) | |
|---|---|---|
| Mean age in years | 50 ± 15 | |
| Male | 76.36 | |
| Female | 23.64 | |
| Asthma | 15.1 | |
| Diabetes | 18.1 | |
| Hypertension | 13.9 | |
| Liver diseases (hepatitis B & C) | 4.2 | |
| Whooping cough | 92.1 | |
| Dyspnea | 80 | |
| Flu | 6.6 | |
| Sore throat | 81.8 | |
| Vomiting | 78.78 | |
| Weight loss | 73.9 | |
| Chest pain | 91.5 | |
| Body aches | 72.7 | |
| Loss of taste | 10.3 | |
| Loss of appetite | 86 | |
| Difficulty in walking | 83.6 | |
| Fever (38 °C–39.5 °C) | 80 | |
| Heart rate >95 beats per mint | 52.1 | |
| Lymphocytopenia | 90.9 | |
| Neutrophilia | 89.6 | |
| Infected by asymptomatic carrier | 61.2 | |
| Infected by presymptomatic carrier | 26.5 | |
| Aged (≥50-years) | 60.6 | |
| Young (<50-years) | 39.4 | |
| Mortality in patients aged ≥ 50-years | 20 | |
| Mortality in patients aged < 50-years | 8.4 | |
| Urban area COVID-19 cases | 74.5 | |
| Rural area COVID-19 cases | 25.45 | |
| Died | 18.78 | |
| Recovered | 81.2 | |
| Laboratory indices | Mean (Interquartile range) | Reference values |
| WBC | 14e103 (8–34 e103/µl) | 4–11 e103/µl |
| RBC | 4e106 (3–7.5 e106/µl) | 4–6 e106/µl |
| Platelets | 240e103(210–390 e103/µl) | 150–450 e103/µl |
| Neutrophils | 82.51 (70–98%) | 40–75% |
| Lymphocytes | 10.36 (6–14%) | 20–45% |
| Monocytes | 1.52 (0.8–10%) | 2–10% |
| Eosinophils | 0.29 (0.2–0.5%) | 0–0.6% |
| D-dimer | 3306 (430–8500 ng/ml) | 200 ng/ml |
| LDH | 1463 (350–2680 U/L) | 91–180 U/L |
| Ferritin | 1671 (510–2200 ng/ml) | 30–400 ng/ml |
| CK | 1348 (90–3033 U/L) | 40–175 U/L |
| ESR | 98.94 (70–120 mm/h) | 1–20 mm/h |
| ALT | 124 (17–310 U/L) | 10–50 U/L |
| ALP | 126.5 (45–290 U/L) | 40–130 U/L |
| CRP | 33 (8–45 mg/L) | <6.0 mg/L |
| Troponin-I | 0.87 (0.7–1.5 ng/ml) | <0.6 ng/ml |
| Blood urea | 23.5 (18–55 mg/dl) | 18–45 mg/dl |
| Creatinine | 0.98 (0.7–1.5 mg/dl) | 0.5–1.08 mg/dl |